The North American compression therapy market size is forecasted to be growing at a CAGR of 6.02% from 2024 to 2029.
Commonly used compression therapy includes graduated or medical compression wear and standard compression socks. Graduated compression socks are mostly used for the treatment of chronic venous disorders and edema. The increased demand is also attributed to advancements in technologies related to orthopedic surgeries and the increased awareness of the presence and benefits of compression therapy.
The increasing prevalence of venous disorders such as leg ulcers, deep vein thrombosis, lymphedema, deep vein thrombosis (DTV), and blood clots is a high impact factor in treatment. The products, especially stockings and bandages, are increasingly used to treat the aforementioned disorders, promoting growth. According to the vascular surgery department, chronic venous abnormalities are present in about 52% of individuals. The online advertising of compression therapy and its effectiveness in curing venous disorders has enabled consumers to make informed decisions for their needs and to adopt compression garments in place of traditional stockings and bandages.
The increasing number of orthopedic procedures primarily drives the North American compression therapy market due to a significant increase in accidents and the obese population worldwide. In addition, the growing geriatric population is susceptible to orthopedic conditions, which contributes to the high number of orthopedic procedures. These factors lead to an increase in the consumption of the products. According to the American Academy of Orthopedic Surgeons, knee and hip replacements are expected to increase by as much as 675% and 179%, respectively, over the next two decades. This unprecedented growth in orthopedic procedures illustrates the demand for compression therapy products.
The limiting factors associated with compression therapy are the lack of standardization of the manufacturing process, the lesser focus on promotional campaigns organized in areas other than medical use, and the effect of the material on the characteristics of the product.
Impact of COVID-19 on the North American Compression Therapy Market:
The COVID-19 pandemic outbreak has affected relevant end-user industries in the North American region, negatively impacting the compression therapy industry. Major markets, including the United States and Canada, are also affected. However, the United States resumed market activities from the second half of 2020, with production and factories back on track. However, it will take at least a quarter or two to regain its previous market momentum.
The United States was the primary market for the North American region. The United States dominates the North American region with a total market share of 95% and is expected to continue to experience strong growth during the forecast period. The growth of the geriatric population and the high incidence of chronic venous disorders and obesity are the reasons for the participation achieved by this region in previous years. The presence of favorable government reimbursement schemes and increasing levels of healthcare awareness are also key factors contributing to growth in this region. In addition, the presence of a large number of established pharmaceutical companies, constantly striving to achieve wide commercialization and improve their geographic reach, is believed to be a key factor responsible for future growth in this region.
Style trends for girdles have undergone constant changes in the United States. In the United States, women are turning more to fashionable fitness clothing. Several other popular shapewear includes belts, panties, shapewear, and corsets. According to a recent review from the Centers for Disease Control and Prevention, approximately 900,500 people in the U.S. could be affected by DTV due to a modern lifestyle. About 12-30% of the population with DTV is expected to die within one month of diagnosis.
Countries such as Canada and Mexico also have huge opportunities in the upcoming years.
Medi GmbH & Co., Medtronic Plc, Julius Zorn GmbH, SIGVARIS, Hartmann AG, BSN Medical GmbH, ArjoHuntleigh, 3M Health Care, Spectrum Healthcare, Bio Compression Systems, Inc. and Gottfried Medical are a few of the leading companies in the North American compression therapy market.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region